Articles with public access mandates - Hans EhrencronaLearn more
Not available anywhere: 3
Review
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
AM Halldórsdóttir, A Lundin, F Murray, L Mansouri, S Knuutila, ...
Leukemia 25 (12), 1904-1908, 2011
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Review
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
A Stenzinger, A Edsjö, C Ploeger, M Friedman, S Fröhling, V Wirta, ...
Seminars in Cancer Biology 84, 242-254, 2022
Mandates: Vinnova, Sweden
Review
Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia
R Rosenquist, H Ehrencrona, H Hasle, J Palle, M Kanduri
Leukemia 27 (2), 510-512, 2013
Mandates: Swedish Research Council
Available somewhere: 54
Review
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Mandates: US National Institutes of Health, Cancer Research UK, National Institute for …
Review
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ...
The Lancet Oncology 19 (6), 747-757, 2018
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Review
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general …
AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ...
Nature genetics 42 (10), 885-892, 2010
Mandates: US National Institutes of Health, Cancer Research UK
Review
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ...
Journal of clinical oncology 38 (7), 674-685, 2020
Mandates: US National Institutes of Health, Research Foundation (Flanders), Research …
Review
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
NCP Cross, HE White, D Colomer, H Ehrencrona, L Foroni, E Gottardi, ...
Leukemia 29 (5), 999-1003, 2015
Mandates: European Commission
Review
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ...
JNCI: Journal of the National Cancer Institute 109 (7), djw302, 2017
Mandates: US Department of Defense, US National Institutes of Health, National Health …
Review
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS genetics 9 (3), e1003212, 2013
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ...
Human mutation 39 (5), 593-620, 2018
Mandates: US Department of Defense, US National Institutes of Health, National Health …
Review
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
M Ilander, U Olsson-Strömberg, H Schlums, J Guilhot, O Brück, ...
Leukemia 31 (5), 1108-1116, 2017
Mandates: Academy of Finland
Review
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ...
Nature medicine 25 (10), 1526-1533, 2019
Mandates: US National Institutes of Health, Swedish Research Council, Cancer Research …
Review
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits
I Tachmazidou, D Süveges, JL Min, GRS Ritchie, J Steinberg, K Walter, ...
The American Journal of Human Genetics 100 (6), 865-884, 2017
Mandates: US National Institutes of Health, Academy of Finland, Versus Arthritis, UK …
Review
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
X Yang, H Song, G Leslie, C Engel, E Hahnen, B Auber, J Horváth, K Kast, ...
JNCI: Journal of the National Cancer Institute 112 (12), 1242-1250, 2020
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ...
Nature genetics 48 (4), 374-386, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
AC Antoniou, OM Sinilnikova, L McGuffog, S Healey, H Nevanlinna, ...
Human molecular genetics 18 (22), 4442-4456, 2009
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
CA Maxwell, J Benítez, L Gómez-Baldó, A Osorio, N Bonifaci, ...
PLoS biology 9 (11), e1001199, 2011
Mandates: US National Institutes of Health, Cancer Research UK, Government of Spain
Publication and funding information is determined automatically by a computer program